We are live on
!
Find out more
RCMNY
Rubric Capital Management (New York) Portfolio holdings
AUM
$8.16B
1-Year Est. Return
68.42%
This Fund
S&P 500
This Quarter
Est. Return
+4.71%
1 Year Est. Return
+68.42%
3 Year Est. Return
+212.09%
5 Year Est. Return
+270.59%
10 Year Est. Return
–
AUM
$8.16B
AUM Growth
-$199M
(-2.4%)
Cap. Flow
-$283M
Cap. Flow
% of AUM
-3.46%
Top 10 Holdings %
Top 10 Hldgs %
52.32%
Holding
92
New
15
Increased
26
Reduced
14
Closed
9
Top Buys
| 1 |
Viatris
VTRS
|
+$112M |
| 2 |
Zoom
ZM
|
+$83.8M |
| 3 |
Gildan
GIL
|
+$73.7M |
| 4 |
Edgewell Personal Care
EPC
|
+$60.3M |
| 5 |
Amcor
AMCR
|
+$56.1M |
Top Sells
| 1 |
FTAI Aviation
FTAI
|
+$298M |
| 2 |
Teva Pharmaceuticals
TEVA
|
+$196M |
| 3 |
Fluor
FLR
|
+$164M |
| 4 |
Roivant Sciences
ROIV
|
+$103M |
| 5 |
Vistra
VST
|
+$80.9M |
Sector Composition
| 1 | Healthcare | 31.98% |
| 2 | Utilities | 22.77% |
| 3 | Industrials | 11.29% |
| 4 | Energy | 7.86% |
| 5 | Communication Services | 6.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
PUT
iShares Russell 2000 ETF
IWM
$82.7B
| $1.28B | 15.65% |
+5,150,000
| New | +$1.33B |
|
|
TLN
2
Talen Energy Corp
TLN
$19.1B
| $1.15B | 14.09% |
3,602,171
| – | – |
|
|
3
FTAI Aviation
FTAI
$21.9B
| $631M | 7.73% |
2,576,186
-1,123,814
| -30% | -$298M |
|
4
Golar LNG
GLNG
$5.16B
| $497M | 6.08% |
9,178,978
| – | – |
|
|
5
Teva Pharmaceuticals
TEVA
$36.7B
| $459M | 5.63% |
15,250,000
-6,105,510
| -29% | -$196M |
|
|
6
Viatris
VTRS
$19.4B
| $453M | 5.54% |
33,500,000
+8,000,000
| +31% | +$112M |
|
7
TransAlta
TAC
$4.3B
| $233M | 2.85% |
17,781,325
| – | – |
|
8
BGC Group
BGC
$5.38B
| $228M | 2.79% |
23,300,000
+2,300,000
| +11% | +$21.3M |
|
|
9
Vistra
VST
$54B
| $225M | 2.76% |
1,500,000
-500,000
| -25% | -$80.9M |
|
10
Constellation Energy
CEG
$92.2B
| $200M | 2.45% |
715,000
+45,000
| +7% | +$13.7M |
|
11
Arcutis Biotherapeutics
ARQT
$3.47B
| $195M | 2.39% |
8,271,577
| – | – |
|
12
Mercury Insurance
MCY
$5.83B
| $190M | 2.33% |
2,154,504
+100,000
| +5% | +$8.94M |
|
13
Kiniksa Pharmaceuticals
KNSA
$4.75B
| $181M | 2.21% |
3,750,000
+421,347
| +13% | +$18.7M |
|
14
Zymeworks
ZYME
$1.81B
| $175M | 2.15% |
7,000,000
+1,250,000
| +22% | +$29.6M |
|
15
Akamai
AKAM
$17.4B
| $149M | 1.83% |
1,300,000
+100,000
| +8% | +$10M |
|
16
Liberty Global Class A
LBTYA
$3.64B
| $142M | 1.74% |
11,752,855
+1,734,423
| +17% | +$20.2M |
|
|
17
Roivant Sciences
ROIV
$25.1B
| $139M | 1.7% |
5,000,000
-4,000,000
| -44% | -$103M |
|
18
Amneal Pharmaceuticals
AMRX
$5.49B
| $137M | 1.68% |
11,037,589
-1,297,352
| -11% | -$17.4M |
|
19
Liberty Latin America Class C
LILAK
$1.51B
| $136M | 1.66% |
16,934,973
+5,212,344
| +44% | +$37.2M |
|
20
Delek US
DK
$3.65B
| $121M | 1.48% |
2,687,449
| – | – |
|
21
Cimpress
CMPR
$2.5B
| $119M | 1.46% |
1,629,419
+104,419
| +7% | +$7.72M |
|
22
Ecovyst
ECVT
$1.34B
| $117M | 1.44% |
9,136,067
-1,363,933
| -13% | -$15.4M |
|
23
Liberty Global Class C
LBTYK
$3.53B
| $109M | 1.33% |
9,259,361
+3,137,779
| +51% | +$36M |
|
24
Adeia
ADEA
$3.05B
| $103M | 1.26% |
4,284,205
| – | – |
|
|
25
Edgewell Personal Care
EPC
$1.28B
| $85.4M | 1.05% |
4,000,000
+2,992,929
| +297% | +$60.3M |
|
Similar funds
CCM
CL
WJWM
LGF
CLOS
JFG
CCM
OC